These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 19543291)
61. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex. Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870 [TBL] [Abstract][Full Text] [Related]
62. Identification of lamprey variable lymphocyte receptors that target the brain vasculature. Lajoie JM; Katt ME; Waters EA; Herrin BR; Shusta EV Sci Rep; 2022 Apr; 12(1):6044. PubMed ID: 35411012 [TBL] [Abstract][Full Text] [Related]
63. Role of electrostatics in antibody-antigen association: anti-hen egg lysozyme/lysozyme complex (HyHEL-5/HEL). Slagle SP; Kozack RE; Subramaniam S J Biomol Struct Dyn; 1994 Oct; 12(2):439-56. PubMed ID: 7702779 [TBL] [Abstract][Full Text] [Related]
64. Variable Lymphocyte Receptors: A Current Overview. Kasahara M Results Probl Cell Differ; 2015; 57():175-92. PubMed ID: 26537382 [TBL] [Abstract][Full Text] [Related]
65. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669 [TBL] [Abstract][Full Text] [Related]
66. Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Sinha N; Mohan S; Lipschultz CA; Smith-Gill SJ Biophys J; 2002 Dec; 83(6):2946-68. PubMed ID: 12496069 [TBL] [Abstract][Full Text] [Related]
67. Antigen mobility in the combining site of an anti-peptide antibody. Cheetham JC; Raleigh DP; Griest RE; Redfield C; Dobson CM; Rees AR Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7968-72. PubMed ID: 1716767 [TBL] [Abstract][Full Text] [Related]
68. Use of two-dimensional 1H nuclear magnetic resonance to study high-affinity antibody-peptide interactions. Cheetham JC; Redfield C; Griest RE; Raleigh DP; Dobson CM; Rees AR Methods Enzymol; 1991; 203():202-28. PubMed ID: 1762556 [No Abstract] [Full Text] [Related]
69. X-ray snapshots of the maturation of an antibody response to a protein antigen. Li Y; Li H; Yang F; Smith-Gill SJ; Mariuzza RA Nat Struct Biol; 2003 Jun; 10(6):482-8. PubMed ID: 12740607 [TBL] [Abstract][Full Text] [Related]
70. Structural origins of hemostasis and adaptive immunity. Ware J; Varughese KI Res Pract Thromb Haemost; 2017 Oct; 1(2):286-290. PubMed ID: 30046698 [TBL] [Abstract][Full Text] [Related]
71. The Complement System of Agnathans. Matsushita M Front Immunol; 2018; 9():1405. PubMed ID: 29967624 [TBL] [Abstract][Full Text] [Related]
72. Amino acid sequence of Egyptian goose egg-white lysozyme and effects of amino acid substitution on the enzymatic activity. Kawamura S; Toshima G; Chijiiwa Y; Torikata T; Araki T Biosci Biotechnol Biochem; 2012; 76(4):691-8. PubMed ID: 22484934 [TBL] [Abstract][Full Text] [Related]
73. Design of a binding scaffold based on variable lymphocyte receptors of jawless vertebrates by module engineering. Lee SC; Park K; Han J; Lee JJ; Kim HJ; Hong S; Heu W; Kim YJ; Ha JS; Lee SG; Cheong HK; Jeon YH; Kim D; Kim HS Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3299-304. PubMed ID: 22328160 [TBL] [Abstract][Full Text] [Related]
74. Variable lymphocyte receptor recognition of the immunodominant glycoprotein of Bacillus anthracis spores. Kirchdoerfer RN; Herrin BR; Han BW; Turnbough CL; Cooper MD; Wilson IA Structure; 2012 Mar; 20(3):479-86. PubMed ID: 22405006 [TBL] [Abstract][Full Text] [Related]
75. Molecular dynamics simulation of a high-affinity antibody-protein complex: the binding site is a mosaic of locally flexible and preorganized rigid regions. Sinha N; Smith-Gill SJ Cell Biochem Biophys; 2005; 43(2):253-73. PubMed ID: 16049350 [TBL] [Abstract][Full Text] [Related]
76. Evolution of Alternative Adaptive Immune Systems in Vertebrates. Boehm T; Hirano M; Holland SJ; Das S; Schorpp M; Cooper MD Annu Rev Immunol; 2018 Apr; 36():19-42. PubMed ID: 29144837 [TBL] [Abstract][Full Text] [Related]
77. Re-evaluation of the immunological Big Bang. Flajnik MF Curr Biol; 2014 Nov; 24(21):R1060-5. PubMed ID: 25517375 [TBL] [Abstract][Full Text] [Related]
78. Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics. Acchione M; Lee YC; DeSantis ME; Lipschultz CA; Wlodawer A; Li M; Shanmuganathan A; Walter RL; Smith-Gill S; Barchi JJ Biochemistry; 2012 Jul; 51(30):6017-27. PubMed ID: 22769726 [TBL] [Abstract][Full Text] [Related]
79. An inhibitory receptor of VLRB in the agnathan lamprey. Wu F; Chen L; Ren Y; Yang X; Yu T; Feng B; Chen S; Xu A Sci Rep; 2016 Oct; 6():33760. PubMed ID: 27762335 [TBL] [Abstract][Full Text] [Related]
80. Expansions, diversification, and interindividual copy number variations of AID/APOBEC family cytidine deaminase genes in lampreys. Holland SJ; Berghuis LM; King JJ; Iyer LM; Sikora K; Fifield H; Peter S; Quinlan EM; Sugahara F; Shingate P; Trancoso I; Iwanami N; Temereva E; Strohmeier C; Kuratani S; Venkatesh B; Evanno G; Aravind L; Schorpp M; Larijani M; Boehm T Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3211-E3220. PubMed ID: 29555777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]